16.05.2012
What do the tango, which originates in Latin America, and the official soccer ball of the same name for this year's European Soccer Championship have in common? A variety of steps, sometimes fast, sometimes slow, an armory of twists and turns and endless vitality. Soccer fans are looking forward once again to watching exciting games in stadiums, beer gardens and their living rooms during UEFA EURO 2012 in June.
more15.05.2012
The 2008-2009 crisis signaled the start of a paradigm shift in chemical plant engineering and construction. Traditional EPC (engineering, procurement and construction) suppliers (general contractors based in the Western industrialized nations) are facing increased competition from Asia. At the same time, the plant engineering teams at global chemical companies are intensifying their partnerships with EPC suppliers and spreading the workload across the international engineering resource base.
more12.04.2012
Bayer MaterialScience will acquire Arkema's polycarbonate sheet business in the USA. Both companies have signed the agreement. Financial terms are not disclosed.
The acquisition will include Arkema's Tuffak line of products used in areas such as aerospace, transportation and heavy equipment.
more30.03.2012
Effective March 31, Bayer MaterialScience will acquire the remaining shares in the 50:50 systems house joint venture Baulé from Eximium and other shareholders.
The joint venture was established in 2008 by the Leverkusen-based company and Michel Baulé, which later was renamed Eximium.
more27.03.2012
Hidden Value - If one thinks about coal-fired power plants, what is it that comes first into one's mind? The picture of high-value starting materials or rather the picture of low value carbon dioxide (CO2) emissions? Most people will probably end up with the latter one. However, the utilization of CO2 as a valuable raw material is not as devious as one would expect: Advanced research shows that it could be used as new source of carbon - thus replacing at least partially crude oil from which the element is normally extracted.
more15.03.2012
German chemicals and drugs group Bayer expects higher profit margins and sales at its healthcare division over the next three years, where product launches are set to boost prescription drug sales by 16%.
The healthcare division, which also makes non-prescription and animal health drugs, contrast agents and blood glucose meters, is aiming for sales of roughly €20 billion ($26.2 billion) in 2014, up from €17.2 billion last year, Germany's largest drugmaker said.
more09.12.2011
Is it possible to strike a balance between megatrends like climate protection and rising global mobility? What possibilities do plastics offer for increasing the range of electric cars? When it comes to lighting, can energy efficiency, safety and modern design be combined? And how can we conserve dwindling resources if product quality is to remain at a high level? Bayer MaterialScience presented answers to all these questions at this year's Fakuma trade fair in Friedrichshafen.
more01.11.2011
European chemical groups warned of slowing demand in the construction industry on Thursday, compounding problems with rising raw materials costs as they reported third-quarter results on Thursday.
Global chemical industry leader BASF reported higher-than-expected quarterly earnings, but warned that growth was slowing as customers run down inventories.
more06.10.2011
VIP - Visions In Plastics Holographic information can be "embedded" onto photopolymer films using laser beams. Bayer MaterialScience has developed films that are suitable for industrial production, which - unlike existing materials - do not require time-consuming subsequent treatment. A whole host of industries can benefit from the resulting high-performance holograms - from security technology and consumer electronics to the optical industry.
more21.03.2011
Bayer's Chief Executive Marijn Dekkers came with M&A credentials from his previous job last year and investors have been looking for clues where he plans to take the 147 year-old German drugmaker.
He has said a €17 billion ($23.8 billion) takeover deal could be financed, eyeing healthcare and genetically modified seeds as growth areas, and that Bayer's plastics and foams could end up on the block to fund a transformational transaction.
more